{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:59:12Z","timestamp":1791917952906,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cca.2026.121229","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:38:49Z","timestamp":1783600729000},"page":"121229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["NT-IGFBP-4: A novel biomarker for risk prediction in acute heart failure"],"prefix":"10.1016","volume":"592","author":[{"given":"Ling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cca.2026.121229_bb0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: A contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.cca.2026.121229_bb0010","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2026.121229_bb0015","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card. Fail. Rev."},{"issue":"10","key":"10.1016\/j.cca.2026.121229_bb0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.121229_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3920195","article-title":"A review of the molecular mechanisms underlying the development and progression of cardiac remodeling","volume":"2017","author":"Schirone","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.cca.2026.121229_bb0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2022.06.039","article-title":"Biomarkers in heart failure: relevance in the clinical practice","volume":"363","author":"Joury","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2026.121229_bb0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10741-014-9442-y","article-title":"BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review","volume":"19","author":"Santaguida","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2026.121229_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2022.06.055","article-title":"Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure","volume":"363","author":"Kim","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"20","key":"10.1016\/j.cca.2026.121229_bb0045","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.121229_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/00015385.2019.1669847","article-title":"sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure","volume":"75","author":"Barutaut","year":"2020","journal-title":"Acta Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-024-03802-5","article-title":"GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome","volume":"24","author":"Kosum","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"5","key":"10.1016\/j.cca.2026.121229_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin. Res. Cardiol."},{"issue":"11","key":"10.1016\/j.cca.2026.121229_bb0065","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1134\/S0006297921110043","article-title":"IGFBP-4 proteolysis by PAPP-A in a primary culture of rat neonatal cardiomyocytes under Normal and hypertrophic conditions","volume":"86","author":"Serebryanaya","year":"2021","journal-title":"Biochemistry (Mosc)"},{"issue":"9","key":"10.1016\/j.cca.2026.121229_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098420","article-title":"PAPP-A-specific IGFBP-4 proteolysis in human induced pluripotent stem cell-derived cardiomyocytes","volume":"24","author":"Adasheva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121229_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2024.101625","article-title":"Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease","volume":"79","author":"Conover","year":"2024","journal-title":"Growth Hormon. IGF Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121229_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12079-015-0259-9","article-title":"The role of PAPP-A in the IGF system: location, location, location","volume":"9","author":"Oxvig","year":"2015","journal-title":"J. Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.cca.2026.121229_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0304-4165(94)90071-X","article-title":"Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein","volume":"1201","author":"Oxvig","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.cca.2026.121229_bb0090","first-page":"847","article-title":"Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro","volume":"86","author":"Byun","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7\u20138","key":"10.1016\/j.cca.2026.121229_bb0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2011.12.030","article-title":"N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia","volume":"45","author":"Postnikov","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121229_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ghir.2018.05.002","article-title":"IGFBP-4 and PAPP-A in normal physiology and disease","volume":"41","author":"Hjortebjerg","year":"2018","journal-title":"Growth Hormon. IGF Res."},{"issue":"5","key":"10.1016\/j.cca.2026.121229_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/00365513.2017.1325926","article-title":"Pregnancy-associated plasma protein-A (PAPP-A) and the proform of the eosinophil major basic protein (ProMBP) are associated with increased risk of death in heart failure patients","volume":"77","author":"Dembic","year":"2017","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.cca.2026.121229_bb0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2012.04.023","article-title":"Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes","volume":"60","author":"Bonaca","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3\u20134","key":"10.1016\/j.cca.2026.121229_bb0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cca.2010.11.024","article-title":"Studies on the effects of heparin products on pregnancy-associated plasma protein A","volume":"412","author":"Wittfooth","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"4\u20135","key":"10.1016\/j.cca.2026.121229_bb0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinbiochem.2014.11.022","article-title":"PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI","volume":"48","author":"Hjortebjerg","year":"2015","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.cca.2026.121229_bb0125","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.clinbiochem.2015.05.010","article-title":"Characterization of endogenously circulating IGFBP-4 fragments-novel biomarkers for cardiac risk assessment","volume":"48","author":"Konev","year":"2015","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1515\/cclm-2025-0378","article-title":"An automatic chemiluminescence immunoassay for a novel biomarker NT-IGFBP-4: analytical performance and clinical relevance in heart failure","volume":"64","author":"Cao","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121229_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005358","article-title":"Insulin-like growth factor binding protein 4 fragments provide incremental prognostic information on cardiovascular events in patients with ST-segment elevation myocardial infarction","volume":"6","author":"Hjortebjerg","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.cca.2026.121229_bb0140","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1210\/jc.2015-2196","article-title":"IGFBP-4 fragments as markers of cardiovascular mortality in type 1 diabetes patients with and without nephropathy","volume":"100","author":"Hjortebjerg","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2026.121229_bb0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ehf2.12590","article-title":"CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure","volume":"7","author":"Konev","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"Authors\/Task Force M","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2023.09.030","article-title":"Standardized definitions for evaluation of acute decompensated heart failure therapies: HF-ARC expert panel paper","volume":"12","author":"Lala","year":"2024","journal-title":"JACC Heart Fail."},{"issue":"8","key":"10.1016\/j.cca.2026.121229_bb0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ajem.2013.04.038","article-title":"Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure","volume":"31","author":"Golcuk","year":"2013","journal-title":"Am. J. Emerg. Med."},{"issue":"4\u20135","key":"10.1016\/j.cca.2026.121229_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinbiochem.2007.10.005","article-title":"Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP","volume":"41","author":"Balion","year":"2008","journal-title":"Clin. Biochem."},{"issue":"8","key":"10.1016\/j.cca.2026.121229_bb0170","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1373\/clinchem.2015.239673","article-title":"Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus cardiac examination 2 study","volume":"61","author":"Rosjo","year":"2015","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.29245\/2578-3009\/2023\/1.1245","article-title":"Natriuretic peptides in clinical practice: a current review","volume":"7","author":"Lee","year":"2023","journal-title":"J. Immunol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121229_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1373\/clinchem.2016.254714","article-title":"Natriuretic peptides and analytical barriers","volume":"63","author":"Vasile","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121229_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinbiochem.2018.03.004","article-title":"Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients","volume":"55","author":"Konev","year":"2018","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.cca.2026.121229_bb0190","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ejhf.1771","article-title":"Sex-related differences in contemporary biomarkers for heart failure: a review","volume":"22","author":"Suthahar","year":"2020","journal-title":"Eur. J. Heart Fail."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:50:23Z","timestamp":1788900623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":38,"alternative-id":["S0009898126004110"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121229","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT-IGFBP-4: A novel biomarker for risk prediction in acute heart failure","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121229"}}